Pharmacology, Toxicology and Pharmaceutical Science
Lung Aspergillosis
90%
Aspergillus
34%
Posaconazole
22%
Metallo Beta Lactamase
20%
Disease
20%
Antifungal Agent
18%
Adverse Event
17%
Aspergillosis
17%
Bloodstream Infection
17%
Asthma
16%
Enterobacteriaceae
15%
Chronic Obstructive Lung Disease
14%
Therapeutic Drug Monitoring
14%
Lateral Flow Assay
14%
Klebsiella pneumoniae
13%
Voriconazole
13%
Prevalence
11%
Gamma Interferon
11%
Immunotherapy
10%
Infection
10%
Observational Study
9%
Bacteremia
9%
Allergic Bronchopulmonary Aspergillosis
9%
Prospective Study
9%
Pharmacokinetics
8%
Chemotherapy
8%
Paclitaxel
8%
HIV
8%
Mould
7%
Symptom
7%
Pyrrole
7%
Isavuconazole
7%
Enzyme Immunoassay
6%
Respiratory Virus
6%
Delayed Release
6%
Effusion
6%
Aminoglycoside
6%
Farm Animal
6%
Micafungin
6%
Anthracycline
6%
Skin Carcinoma
6%
Antimicrobial Therapy
6%
Tenofovir
6%
Carbapenem
6%
Lamivudine
6%
Darunavir Plus Ritonavir
6%
Breast Cancer
6%
Antibodies
6%
Docetaxel
6%
Irinotecan
6%
Medicine and Dentistry
Chronic Pulmonary Aspergillosis
100%
Aspergillus
43%
Diseases
29%
Antifungal Therapy
22%
Histoplasmosis
20%
Lung Aspergillosis
19%
Lateral Flow Assay
16%
Antifungal Agent
15%
Allergic Bronchopulmonary Aspergillosis
14%
Chronic Obstructive Pulmonary Disease
13%
Metallo Beta Lactamase
13%
Lung Tuberculosis
12%
Diagnosis
12%
Symptom
11%
Daptomycin
10%
Mycosis
9%
Gram Positive Infection
9%
Gram-Positive Bacteria
9%
Prevalence
9%
Infection
9%
Invasive Aspergillosis
9%
Human Immunodeficiency Virus
8%
Surgery
8%
Sensitization
8%
Bacteremia
8%
Outpatient
8%
Enzyme Immunoassay
8%
Itraconazole
8%
Posaconazole
7%
Cohort Effect
7%
Treatment Response
7%
Biopsy
7%
Klebsiella pneumoniae
6%
Hematologic Malignancy
6%
Carbapenem Derivative
6%
Pyrrole
6%
Health Status
6%
Fatality
6%
Surgical Infection
6%
Prospective Study
6%
Coagulase Positive Staphylococcus
6%
Coagulase
6%
Antibodies
6%
Pulmonary Embolism
6%
Duodenum
6%
Febrile Neutropenia
6%
Antigen
6%
Patient Referral
6%
Zygomycosis
6%
Bariatric Surgery
6%
Immunology and Microbiology
Aspergillus
41%
Prevalence
30%
Integron
25%
Enterobacteriaceae
20%
Staphylococcus Aureus
20%
Minimum Inhibitory Concentration
20%
Escherichia coli
16%
Monospecific Antibody
14%
Multidrug Resistance
14%
Immunodeficiency
14%
Lateral Flow Assay
14%
Gene Expression
13%
Klebsiella pneumoniae
13%
Allergic Bronchopulmonary Aspergillosis
13%
Human Immunodeficiency Virus
10%
Pseudomonas aeruginosa
9%
Sensitization
8%
CD19
8%
Infectious Agent
8%
Antifungal Susceptibility
7%
C-Reactive Protein
7%
Serology
7%
Antigen
6%
Western Blot
6%
Severe Asthma
6%
Ajellomyces capsulatus
6%
Procalcitonin
6%
Vaccination Policy
6%
Antibody Screening
6%
Methicillin-Resistant Staphylococcus Aureus
6%
Farm Animal
6%
Aspergillus fumigatus
6%
Age Distribution
6%
Sputum
6%
Mycobiome
6%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
6%
Lymphocytopenia
6%
Asthma
6%
Respiratory Virus
6%
Bacterial Microbiome
6%
Genetic Correlation
6%
Interferon Gamma
6%
Enzyme Immunoassay
6%
Computer Model
6%
Immunoaffinity Chromatography
6%
Mould
6%
Histoplasma
6%
Polymerase Chain Reaction
6%
Medline
5%
Etest
5%
